Plasma samples obtained from HCV infected subjects in the BBAASH cohort [15 (link),16 (link),45 ], Irish Anti-D cohort [46 (link)], and Swan Project [47 (link)] were used to construct a library of genotype 1 E1E2-expressing lentiviral pseudoparticles using a high-throughput production and screening approach. The E1E2 region was PCR amplified from cDNA reverse transcribed from viral RNA purified from subject plasma and cloned into the expression vector pcDNA3.2/V5/Dest (Invitrogen) using Gateway technology in a one-tube BP/LR reaction, as previously described [19 ].
Free full text: Click here